Histopathological analyses seem to corroborate these findings because the increased immunohistochemical levels of ALDH1, CD44, or pSTAT3 were associated with shorter overall survival in HNSCC patients, while the worst survival rate was observed in triple-positive patients (Chen et al. 2010). This evidence concerns the gene CD44 and head and neck squamous cell carcinoma.